Market Research Logo

Allergan Plc (AGN) - Product Pipeline Analysis, 2018 Update

Summary

Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, women’s health, urology and anti-infective therapeutic categories. The company sells its products to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations in several countries across the Americas, Europe, Asia-Pacific, the Middle East and Africa. Allergan is headquartered in Dublin, Ireland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Allergan Plc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Allergan Plc Company Overview
Allergan Plc Company Snapshot
Allergan Plc Pipeline Products and Ongoing Clinical Trials Overview
Allergan Plc – Pipeline Analysis Overview
Business Description
Allergan Plc - Key Facts
Allergan Plc - Major Products and Services
Allergan Plc Pipeline Products by Development Stage
Allergan Plc Ongoing Clinical Trials by Trial Status
Allergan Plc Pipeline Products Overview
BotuGel
BotuGel Product Overview
BotuGel Clinical Trial
CoolSculpting - Pseudogynocomastia
CoolSculpting - Pseudogynocomastia Product Overview
CoolSculpting Mini V2
CoolSculpting Mini V2 Product Overview
Diafert
Diafert Product Overview
earFold
earFold Product Overview
earFold Clinical Trial
Eplica Silk
Eplica Silk Product Overview
HA Threads
HA Threads Product Overview
Helios Insert
Helios Insert Product Overview
JUVEDERM Volbella
JUVEDERM Volbella Product Overview
Juvederm Volift - Nasolabial Folds
Juvederm Volift - Nasolabial Folds Product Overview
LILETTA - 5 Years
LILETTA - 5 Years Product Overview
LiRIS
LiRIS Product Overview
MicroCell - Breast Augmentation
MicroCell - Breast Augmentation Product Overview
Nanotechnology-Based Transdermal Delivery System
Nanotechnology-Based Transdermal Delivery System Product Overview
Norethindrone Transdermal Delivery System
Norethindrone Transdermal Delivery System Product Overview
NOVADUR Intravitreal Implant
NOVADUR Intravitreal Implant Product Overview
OD-01
OD-01 Product Overview
Phoenix - Breast Augmentation
Phoenix - Breast Augmentation Product Overview
SeriGel
SeriGel Product Overview
Thigh Applicator
Thigh Applicator Product Overview
Vaginal Ring Contraceptive
Vaginal Ring Contraceptive Product Overview
VYC-25L Hyaluronic Acid Injectable Gel
VYC-25L Hyaluronic Acid Injectable Gel Product Overview
Zeltiq Applicator - Acne
Zeltiq Applicator - Acne Product Overview
Zeltiq Applicator - Cellulite
Zeltiq Applicator - Cellulite Product Overview
Allergan Plc - Key Competitors
Allergan Plc - Key Employees
Allergan Plc - Key Employee Biographies
Allergan Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Allergan Plc, Recent Developments
May 07, 2018: Medicines360, WCG, and Population Services International Announce Launch of AVIBELA Hormonal Intrauterine System in Madagascar
May 03, 2018: John Davidson Elected to Allergan Board of Directors
Apr 30, 2018: Allergan Reports 3% Increase in First Quarter 2018 GAAP Net Revenues to $3.7 Billion
Apr 26, 2018: Allergan to Present New Data at the American College of Obstetrics and Gynecology 67th Annual Clinical and Scientific Meeting 2018
Apr 13, 2018: Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting
Mar 06, 2018: CoolSculpting Takes to the Ice with Iconic Figure Skater Johnny Weir to Debunk Fat Loss Myths
Feb 22, 2018: Access Vascular Receives FDA Clearance for its HydroPICC Catheter
Feb 22, 2018: FDA Acceptance of Medicines360's Filing for supplemental New Drug Application for LILETTA (levonorgestrel-releasing intrauterine system) 52 mg
Feb 05, 2018: Allergan Appoints Matthew M. Walsh As Executive Vice President and Chief Financial Officer
Feb 01, 2018: Japanese Pharmaceutical Company Agrees to 20 Year Settlement Agreement after Attempting to Block Generics
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Allergan Plc Pipeline Products and Ongoing Clinical Trials Overview
Allergan Plc Pipeline Products by Equipment Type
Allergan Plc Pipeline Products by Indication
Allergan Plc Ongoing Clinical Trials by Trial Status
Allergan Plc, Key Facts
Allergan Plc, Major Products and Services
Allergan Plc Number of Pipeline Products by Development Stage
Allergan Plc Pipeline Products Summary by Development Stage
Allergan Plc Ongoing Clinical Trials by Trial Status
Allergan Plc Ongoing Clinical Trials Summary
BotuGel - Product Status
BotuGel - Product Description
BotuGel - Phase II Study of OnabotulinumtoxinA SR Overactive Bladder
CoolSculpting - Pseudogynocomastia - Product Status
CoolSculpting - Pseudogynocomastia - Product Description
CoolSculpting Mini V2 - Product Status
CoolSculpting Mini V2 - Product Description
Diafert - Product Status
Diafert - Product Description
earFold - Product Status
earFold - Product Description
earFold - Long Term Prospective Uncontrolled Study of Earfold or the Treatment of Prominent Ears: FOLD
Eplica Silk - Product Status
Eplica Silk - Product Description
HA Threads - Product Status
HA Threads - Product Description
Helios Insert - Product Status
Helios Insert - Product Description
JUVEDERM Volbella - Product Status
JUVEDERM Volbella - Product Description
Juvederm Volift - Nasolabial Folds - Product Status
Juvederm Volift - Nasolabial Folds - Product Description
LILETTA - 5 Years - Product Status
LILETTA - 5 Years - Product Description
LiRIS - Product Status
LiRIS - Product Description
MicroCell - Breast Augmentation - Product Status
MicroCell - Breast Augmentation - Product Description
Nanotechnology-Based Transdermal Delivery System - Product Status
Nanotechnology-Based Transdermal Delivery System - Product Description
Norethindrone Transdermal Delivery System - Product Status
Norethindrone Transdermal Delivery System - Product Description
NOVADUR Intravitreal Implant - Product Status
NOVADUR Intravitreal Implant - Product Description
OD-01 - Product Status
OD-01 - Product Description
Phoenix - Breast Augmentation - Product Status
Phoenix - Breast Augmentation - Product Description
SeriGel - Product Status
SeriGel - Product Description
Thigh Applicator - Product Status
Thigh Applicator - Product Description
Vaginal Ring Contraceptive - Product Status
Vaginal Ring Contraceptive - Product Description
VYC-25L Hyaluronic Acid Injectable Gel - Product Status
VYC-25L Hyaluronic Acid Injectable Gel - Product Description
Zeltiq Applicator - Acne - Product Status
Zeltiq Applicator - Acne - Product Description
Zeltiq Applicator - Cellulite - Product Status
Zeltiq Applicator - Cellulite - Product Description
Allergan Plc, Key Employees
Allergan Plc, Key Employee Biographies
Allergan Plc, Other Locations
Allergan Plc, Subsidiaries
Glossary
List of Figures
Allergan Plc Pipeline Products by Equipment Type
Allergan Plc Pipeline Products by Development Stage
Allergan Plc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report